Petros Papastogiannidis

Statistics

Publications

Citations

758

H-Index

Active since

2010

Affiliations

Swiss Tropical and Public Health Institute(Current)

University of Basel

Broad Institute

Roche (Switzerland)

GlaxoSmithKline (Spain)

Petros Papastogiannidis is an author at Swiss Tropical and Public Health Institute specializing in drug discovery, antimalarial agents, and antimalarial drug development.

Publications per year

2010–2017

Publications

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe‐Barnes, Ian Bathurst et al. · Proceedings of the National Academy of Sciences · 2011 · 376 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model*

Michael L. Booker, Cecilia M. Bastos, Martin Kramer et al. · Journal of Biological Chemistry · 2010 · 136 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Passive Immunoprotection of <i>Plasmodium falciparum</i>-Infected Mice Designates the CyRPA as Candidate Malaria Vaccine Antigen

Anita M. Dreyer, Hugues Matile, Petros Papastogiannidis et al. · The Journal of Immunology · 2012 · 80 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Structure–Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)

Yuxiang Dong, Xiaofang Wang, K. Sriraghavan et al. · Journal of Medicinal Chemistry · 2017 · 60 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Optimization of Potent Inhibitors of <i>P. falciparum</i> Dihydroorotate Dehydrogenase for the Treatment of Malaria

Renato T. Skerlj, Cecilia M. Bastos, Michael L. Booker et al. · ACS Medicinal Chemistry Letters · 2011 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–5 of 7